P911 Dr. Ing. h.c. F. Porsche AG
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services. It also offers leasing, dealer and customer financing, mobility services for Porsche brand vehicles, and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was founded in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsche AG is a subsidiary of Porsche Holding Stuttgart GmbH.…
Industry Peers
Auto ManufacturersKey Statistics
About Dr. Ing. h.c. F. Porsche (ETR: P911)
›
Dr. Ing. h.c. F. Porsche (ETR: P911) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Auto Manufacturers industry, part of the Consumer Cyclical sector, and reports about 38,481 employees.
The shares were at 43.08 EUR on 19 November 2026, down 4.8% over 52 weeks. Its 52-week range is 35.62 EUR to 50.66 EUR: the price is 15.0% below the high and 20.9% above the low.
At a market capitalisation of 39.32B EUR, it trades at 18.0 times trailing earnings and 25.9 times forward earnings. The median trailing P/E of its 13 largest Auto Manufacturers peers is 17.9, so P911 is valued in line with them. It pays a dividend yielding 2.33% (it pays out 42% of its earnings), against a median of 4.15% among the dividend payers in that peer group.
Dr. Ing. h.c. F. Porsche reports return on equity of 1.9%, an operating margin of 7.0% and revenue down 7.5% year over year.
Its debt exceeds its cash by 3.42B EUR, a debt-to-equity ratio of 0.49. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 18 analysts cover the stock, with an average rating of Hold; their mean price target of 47.29 EUR is 9.8% above the current price.